Coronavirus roundup: Developments in India and rest of world | India News
NEW DELHI: The health ministry on Friday revised the clinical management protocol for treatment of Covid-19 patients. The revised protocol lowered the dosage schedule of investigational drug Remdesivir from six days to five days now. The drug is allowed under emergency use authorization and may be considered in patients with moderate disease (those on oxygen), the new protocol said. The drug cannot be administered to a pregnant or lactating mother and children below the age of 12 years. Also, the patient should not have renal problems. The new treatment protocol also reflected the changed home isolation guidelines for asymptomatic patients. The new protocol also details symptoms and conditions in different stages of treatment. Apart from Remdesivir, convalescent plasma, tocilizumab and
Riddhima Kapoor Sahni is one proud wife as her husband Bharat Sahni, donated plasma to help many others in their battle with Covid-19. Taking to her Instagram Stories, Riddhima posted a picture of Bharat in a hospital char, donating blood. "So proud of you for donating your plasma and saving someone's life today. Well done," she wrote. Not just Riddhima, but mom Neetu Kapoor was also all praise for her son-in-law as she too shared his picture and wrote, "So proud of my son in law @Brat.man for donating his plasma to the critically ill covid patients." She went on to add, “I sincerely hope this inspires a lot of other people to come forward and do the same.” Bharat also did his bit to
NEW DELHI: A single-day spike of 19,459 Covid-19 cases took India's tally to 5,48,318 on Monday, while the death toll climbed to 16,475 with 380 new fatalities, according to the Union health ministry data. This is the sixth consecutive day that coronavirus infections have increased by more than 15,000. The country has seen a surge of 3,57,783 infections from June 1 till date.
NEW DELHI: An inexpensive, widely used steroid dexamethasone was included in the treatment protocols for Covid-19 patients in moderate to severe stages of illness among other therapeutic measures by the Union health ministry on Saturday. The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of Covid-19. The change has been made after considering the latest available evidence and expert consultation, the ministry said. According to the revised 'Clinical Management Protocols for Covid-19', dexamethasone which is already used in treating lung infections besides in a wide range of conditions for its anti-inflammatory and immunosuppressant effects can be used as an alternative to methylprednisolone which already existed in the treatment